KMC Speciality Hospitals (India) Ltd
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
- Market Cap ₹ 1,064 Cr.
- Current Price ₹ 65.2
- High / Low ₹ 95.0 / 57.0
- Stock P/E 49.6
- Book Value ₹ 10.1
- Dividend Yield 0.00 %
- ROCE 17.1 %
- ROE 13.9 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company's median sales growth is 16.9% of last 10 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32 | 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | 177 | 232 | |
| 30 | 31 | 35 | 42 | 56 | 66 | 75 | 79 | 99 | 114 | 129 | 175 | |
| Operating Profit | 2 | 6 | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 42 | 48 | 57 |
| OPM % | 5% | 16% | 19% | 23% | 20% | 20% | 22% | 23% | 28% | 27% | 27% | 25% |
| 3 | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 3 | |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 9 |
| Depreciation | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 | 9 | 19 |
| Profit before tax | -2 | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 | 41 | 32 |
| Tax % | -81% | 0% | 21% | 33% | 32% | 30% | 30% | 29% | 26% | 26% | 25% | 32% |
| -0 | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 | 21 | |
| EPS in Rs | -0.02 | 0.01 | 0.20 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.46 | 1.64 | 1.86 | 1.31 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 19% |
| 3 Years: | 19% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 73% |
| 5 Years: | 13% |
| 3 Years: | -3% |
| TTM: | -30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 27% |
| 3 Years: | 5% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -6 | -6 | -3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 | 127 | 148 |
| 16 | 14 | 10 | 6 | 15 | 10 | 9 | 29 | 29 | 50 | 82 | 89 | |
| 7 | 7 | 6 | 8 | 8 | 10 | 11 | 13 | 13 | 18 | 38 | 32 | |
| Total Liabilities | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 |
| 28 | 25 | 23 | 24 | 37 | 36 | 39 | 74 | 75 | 84 | 206 | 248 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 34 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | 6 | 7 | 14 | 16 | 24 | 31 | 29 | 48 | 63 | 57 | 38 | |
| Total Assets | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 | 38 | 58 | |
| -2 | -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | -48 | -56 | -51 | |
| -1 | -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | 16 | 20 | -2 | |
| Net Cash Flow | 0 | -0 | -0 | 1 | -1 | 1 | -1 | 1 | -0 | 0 | 3 | 4 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 12 | 13 | 12 | 13 | 8 | 8 | 9 | 10 | 10 | 9 | 9 |
| Inventory Days | 48 | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 |
| Days Payable | 187 | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 113 | 153 |
| Cash Conversion Cycle | -129 | -115 | -112 | -94 | -107 | -125 | -48 | -68 | -53 | -56 | -73 | -105 |
| Working Capital Days | -70 | -61 | -50 | -46 | -33 | -28 | -17 | -9 | -7 | -9 | -52 | -4 |
| ROCE % | 2% | 8% | 24% | 35% | 29% | 29% | 33% | 25% | 32% | 27% | 22% | 17% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Jul - Confirmation certificate for securities dematerialization for quarter ended June 30, 2025.
-
Closure of Trading Window
27 Jun - Trading window closed from July 1, 2025, till 48 hours post Q1 results announcement.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
9 Jun - Investor Presentation for the quarter and year ended 31st March , 2025
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Annual Secretarial Compliance Report FY25; minor delay in independent director appointment rectified.
-
Disclosure Under Regulation 30(5) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
28 May - Updated contact details of authorized persons for SEBI disclosure compliance.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Part of Kauvery Group Hospitals
The company is a super-specialty hospital based in Trichy, belonging to the “Kauvery Hospitals group”. The group has more than 2250 beds of multispecialty hospital chains at 12 locations, providing facilities for 1 lakh per year of IP patients and 10 lakhs per year of OP patients. The group is doing more than 600 transplants, 1000+ Joint Replacements, and 1 lakh + Kidney procedures per year. [1] [2]